<DOC>
	<DOCNO>NCT02911480</DOCNO>
	<brief_summary>The current study design phase I multiple dose study evaluate pharmacokinetics bioavailability [ 14C ] -labelled oxytocin healthy woman .</brief_summary>
	<brief_title>Assessment Pharmacokinetics Bioavailability Carbon-14 ( 14C ) -Labelled Oxytocin</brief_title>
	<detailed_description />
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Nonsmoking woman child bear potential ( WOCBP ) Body mass index ( BMI ) ≥ 18.0 ≤ 30.0 kg/m2 Subject must voluntarily sign write informed consent agreement approve Independent Ethics Committee ( IEC ) explanation nature objective study study specific procedure Subject must good physical mental health judge Investigator base evaluation medical gynecological history , physical examination , clinical laboratory , ECG , vital sign data Subject willing able comply condition requirement study Lactation and/or pregnancy previous 6 month screen , whichever applicable Intention become pregnant study within 1 month follow visit History , exist thromboembolic , cardiovascular cerebrovascular disorder Treatment major psychiatric disorder previous 12 month use antidepressant medication screen Any clinically significant abnormality follow review medical history , laboratory result physical examination screen judged Investigator Conditions disorder might affect absorption , distribution , metabolism excretion study drug Contraindications use oxytocin Hypersensitivity active substance excipients investigational product reference therapy Present use use within 30 day start study medication one follow medication : antihypertensive drug , anticoagulant therapy , medication could affect myometrial contractility , sex steroid , prostaglandin analogue , inhalation anesthetic , vasoconstrictors/sympathomimetics caudal anesthetic , vasopressinlike drug Use prescribe overthecounter medication within 14 day Day 1 Administration investigational drug within 3 month Day 1 participation 3 clinical trial 10 month Day 1 Loss 500 milliliter ( mL ) blood 3 month Day 1 , intention donate blood 3 month complete study Subjects positive test result hepatitis B , hepatitis C , human immunodeficiency virus ( HIV ) screen Subjects history alcohol drug abuse positive result screening , test alcohol intake drug abuse</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>